View in EDS HTML Full Text PDF Full Text

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.

Saved in:
Bibliographic Details
Title: Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
Authors: Gonzalez-Perez M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Montes-Casado M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Conde P; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Cervera I; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Baranda J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Berges-Buxeda MJ; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Perez-Olmeda M; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Tarjuelo R; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Utrero-Rico A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lozano-Ojalvo D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Torre D; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Schwarz M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Guccione E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Camara C; Department of Immunology, Hospital La Paz, Madrid, Spain., Llópez-Carratalá MR; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain., Gonzalez-Parra E; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain., Portoles P; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Presidencia, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Ortiz A; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain., Portoles J; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain., Ochando J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Source: Frontiers in immunology [Front Immunol] 2022 Mar 23; Vol. 13, pp. 845882. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35401504
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gonzalez-Perez+M%22">Gonzalez-Perez M</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Montes-Casado+M%22">Montes-Casado M</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Conde+P%22">Conde P</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cervera+I%22">Cervera I</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Baranda+J%22">Baranda J</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Berges-Buxeda+MJ%22">Berges-Buxeda MJ</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Perez-Olmeda+M%22">Perez-Olmeda M</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Tarjuelo+R%22">Sanchez-Tarjuelo R</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Utrero-Rico+A%22">Utrero-Rico A</searchLink>; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Lozano-Ojalvo+D%22">Lozano-Ojalvo D</searchLink>; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Torre+D%22">Torre D</searchLink>; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Schwarz+M%22">Schwarz M</searchLink>; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Guccione+E%22">Guccione E</searchLink>; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Camara+C%22">Camara C</searchLink>; Department of Immunology, Hospital La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Llópez-Carratalá+MR%22">Llópez-Carratalá MR</searchLink>; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Parra+E%22">Gonzalez-Parra E</searchLink>; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Portoles+P%22">Portoles P</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Presidencia, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ortiz+A%22">Ortiz A</searchLink>; Department of Nephrology, Instituto de Investigación Sanitaria (IIS)-Fundación Jimenez Díaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Portoles+J%22">Portoles J</searchLink>; Department of Nephrology, Hospital Puerta de Hierro, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ochando+J%22">Ochando J</searchLink>; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Mar 23; Vol. 13, pp. 845882. <i>Date of Electronic Publication: </i>2022 Mar 23 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35401504
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.845882
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 845882
    Titles:
      – TitleFull: Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Perez M
      – PersonEntity:
          Name:
            NameFull: Montes-Casado M
      – PersonEntity:
          Name:
            NameFull: Conde P
      – PersonEntity:
          Name:
            NameFull: Cervera I
      – PersonEntity:
          Name:
            NameFull: Baranda J
      – PersonEntity:
          Name:
            NameFull: Berges-Buxeda MJ
      – PersonEntity:
          Name:
            NameFull: Perez-Olmeda M
      – PersonEntity:
          Name:
            NameFull: Sanchez-Tarjuelo R
      – PersonEntity:
          Name:
            NameFull: Utrero-Rico A
      – PersonEntity:
          Name:
            NameFull: Lozano-Ojalvo D
      – PersonEntity:
          Name:
            NameFull: Torre D
      – PersonEntity:
          Name:
            NameFull: Schwarz M
      – PersonEntity:
          Name:
            NameFull: Guccione E
      – PersonEntity:
          Name:
            NameFull: Camara C
      – PersonEntity:
          Name:
            NameFull: Llópez-Carratalá MR
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Parra E
      – PersonEntity:
          Name:
            NameFull: Portoles P
      – PersonEntity:
          Name:
            NameFull: Ortiz A
      – PersonEntity:
          Name:
            NameFull: Portoles J
      – PersonEntity:
          Name:
            NameFull: Ochando J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2022 Mar 23
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1